Aurora Cannabis Inc
ACB- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001683541
No open-market purchases or sales by Aurora Cannabis Inc insiders were filed in the last 90 days; 147 institutions reported holding it in 13F filings for Q2 2026, worth $14.8M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −3 vs. previous quarter
- 147
- 13F valueReported value at the end of Q2 2026
- $14.8M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ACB, Q2 2026
No superinvestor reported holding ACB at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Aurora Cannabis Inc insiders from Form 4, newest first.
No open-market purchases or sales by Aurora Cannabis Inc insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Aurora Cannabis Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Goldman Sachs Group Inc | 1,350,837 | $3.77M | 0.00% | +294,619+27.9% | Added |
| Toroso Investments, LLC | 1,264,494 | $3.53M | 0.01% | +14,827+1.2% | Added |
| Renaissance Technologies LLC | 784,955 | $2.19M | 0.00% | +26,774+3.5% | Added |
| National Bank of Canada | 241,055 | $672.5K | 0.00% | −30,235−11.1% | Reduced |
| Morgan Stanley | 240,698 | $671.5K | 0.00% | −18,357−7.1% | Reduced |
| UBS Group AG | 177,561 | $495.4K | 0.00% | +25,293+16.6% | Added |
| AdvisorShares Investments LLC | 171,110 | $477.4K | 0.06% | 00.0% | Unchanged |
| Sculptor Capital LP | 103,700 | $289.3K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 99,199 | $276.2K | 0.00% | +55,676+127.9% | Added |
| TD Asset Management Inc | 94,651 | $263.5K | 0.00% | +5,732+6.4% | Added |